WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Michael E. Coke
Partner
Corporate
Palo Alto
mcoke@wsgr.com

D650-565-3596

Download vCard
LinkedIn
Open PDF
  • Represents Technology Leaders

    Michael has represented innovative companies in transactional matters, including IPOs and other securities offerings; corporate governance and disclosure matters; M&A deals; and venture-backed investments.

  • Broad Industry Experience

    Michael has represented leading companies in several sectors, including the cloud computing, social media, online gaming, networking, data security, life sciences, semiconductor, consumer, energy and financial industries.

  • International Experience and Fluency

    Early in his legal career, Michael spent time in Singapore. He also speaks Thai.

Michael Coke is a partner at Wilson Sonsini, where his practice focuses on a wide variety of corporate, securities, and related matters, primarily for technology companies.

Michael's practice spans the full range of corporate transactions, including representing clients in connection with initial public offerings and other securities offerings, corporate governance and disclosure matters, mergers and acquisitions, and venture-backed private financings. He also has experience advising on secondary market transactions for institutional purchasers. Michael has worked on matters in numerous technology and other industries, including cloud computing software and services, social media and online gaming, network services and devices, data security, biotechnology and life sciences, semiconductor, consumer products, media, public utilities, clean technology, natural resources, insurance, and finance.

Michael has been with the firm since 2006. He started his legal career in New York and Singapore, focusing on public and private offerings of equity, equity-linked securities, and investment-grade and high-yield debt, on both the company and the underwriter side, in addition to mergers and acquisitions and other corporate matters. He also spent six months on secondment to the legal department of JPMorgan Chase Bank's Singapore branch. Michael speaks Thai.

Experience

Michael Coke is a partner at Wilson Sonsini, where his practice focuses on a wide variety of corporate, securities, and related matters, primarily for technology companies.

Michael's practice spans the full range of corporate transactions, including representing clients in connection with initial public offerings and other securities offerings, corporate governance and disclosure matters, mergers and acquisitions, and venture-backed private financings. He also has experience advising on secondary market transactions for institutional purchasers. Michael has worked on matters in numerous technology and other industries, including cloud computing software and services, social media and online gaming, network services and devices, data security, biotechnology and life sciences, semiconductor, consumer products, media, public utilities, clean technology, natural resources, insurance, and finance.

Michael has been with the firm since 2006. He started his legal career in New York and Singapore, focusing on public and private offerings of equity, equity-linked securities, and investment-grade and high-yield debt, on both the company and the underwriter side, in addition to mergers and acquisitions and other corporate matters. He also spent six months on secondment to the legal department of JPMorgan Chase Bank's Singapore branch. Michael speaks Thai.

Education
  • Certificate, Sustainable Capitalism and ESG Online, UC Berkeley School of Law, 2021
  • J.D., Stanford Law School, 1997Member, Stanford Law Review
  • B.A., Political Economy/Anthropology, University of California, Berkeley, 1992Phi Beta Kappa; Junior Year Abroad, Chiang Mai University, Thailand
Admissions
  • State Bar of California
  • State Bar of New York
Credentials
Education
  • Certificate, Sustainable Capitalism and ESG Online, UC Berkeley School of Law, 2021
  • J.D., Stanford Law School, 1997Member, Stanford Law Review
  • B.A., Political Economy/Anthropology, University of California, Berkeley, 1992Phi Beta Kappa; Junior Year Abroad, Chiang Mai University, Thailand
Admissions
  • State Bar of California
  • State Bar of New York

Select Publications

  • Contributor with E. Hill, A Guide to Secondary Transactions: Alternative Paths to Liquidity in Private Companies, Saints Capital Services, LLC, 2010
  • "Success in the Form of an IPO: A Brief Case Study of A123 Systems, Inc.," Nanotechnology Law & Business, Issue 6.4, 2009
Insights

Select Publications

  • Contributor with E. Hill, A Guide to Secondary Transactions: Alternative Paths to Liquidity in Private Companies, Saints Capital Services, LLC, 2010
  • "Success in the Form of an IPO: A Brief Case Study of A123 Systems, Inc.," Nanotechnology Law & Business, Issue 6.4, 2009
Focus Areas
  • Biotech
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Corporate Life Sciences
  • Electronic Gaming
  • Emerging Companies and Venture Capital
  • Life Sciences
  • Mergers & Acquisitions
  • Public Company Representation
  • Software
  • Special Purpose Acquisition Companies (SPACs)
Recent Insights
Client Highlights
Firm Advises 137 Ventures and BANNER VC on Impulse Space’s $500 Million Series D Financing
On June 2, 2026, Impulse Space, an in-space mobility leader, announced it has raised $500 million in Series D funding, bringing the company’s total capital raised to over $1 billion. The funding will support the company’s hiring and manufacturing growth plans in its efforts to build in-space mobility infrastructure. The funding round was co-led by 137 Ventures and BANNER VC with participation from Founder’s Fund, Lux Capital, and Linse Capital. Wilson Sonsini Goodrich & Rosati advised 137 Ventures and BANNER VC on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises ALX Oncology on Public Offering
On January 30, 2026, ALX Oncology Holdings Inc., a clinical-stage biotechnology company focusing on novel therapies designed to treat cancer and extend patients’ lives, announced the pricing of an underwritten offering of 76,979,112 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,574,120 shares of common stock in the offering. The gross proceeds of the offering are expected to be approximately $150 million before deducting the underwriting discounts and commissions and other estimated offering expenses, and excluding the exercise of any pre-funded warrants. Wilson Sonsini Goodrich & Rosati advised ALX Oncology on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.